BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16929354)

  • 1. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
    Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages.
    van Strien ME; Mercier D; Drukarch B; Brevé JJ; Poole S; Binnekade R; Bol JG; Blits B; Verhaagen J; van Dam AM
    Gene Ther; 2010 May; 17(5):662-71. PubMed ID: 20182518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5.
    Nygårdas M; Aspelin C; Paavilainen H; Röyttä M; Waris M; Hukkanen V
    Gene Ther; 2011 Jul; 18(7):646-55. PubMed ID: 21326329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
    J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.
    Linington C; Berger T; Perry L; Weerth S; Hinze-Selch D; Zhang Y; Lu HC; Lassmann H; Wekerle H
    Eur J Immunol; 1993 Jun; 23(6):1364-72. PubMed ID: 7684687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.
    Furlan R; Poliani PL; Galbiati F; Bergami A; Grimaldi LM; Comi G; Adorini L; Martino G
    Hum Gene Ther; 1998 Nov; 9(17):2605-17. PubMed ID: 9853527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
    Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T
    Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
    Krakowski ML; Owens T
    Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
    Cohen SJ; Cohen IR; Nussbaum G
    J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
    Broberg E; Setälä N; Röyttä M; Salmi A; Erälinna JP; He B; Roizman B; Hukkanen V
    Gene Ther; 2001 May; 8(10):769-77. PubMed ID: 11420640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
    Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
    J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine complement C4 is not required for experimental autoimmune encephalomyelitis.
    Boos LA; Szalai AJ; Barnum SR
    Glia; 2005 Jan; 49(1):158-60. PubMed ID: 15390104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
    Furlan R; Poliani PL; Marconi PC; Bergami A; Ruffini F; Adorini L; Glorioso JC; Comi G; Martino G
    Gene Ther; 2001 Jan; 8(1):13-9. PubMed ID: 11402297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.